SELLAS Life Sciences Group (SLS) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.35
-0.29
-0.22
-0.16

Details

Expected EPS
-0.16
Actual EPS
-0.21
Surprise EPS
-0.05
Surprise Percent
+31.25%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.21 per share for Q2 2024.

0 Comments

Share your thoughts